KPC Pharmaceuticals,Inc. (SHA:600422)

Paycor HCM Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Operating Revenue	7,641	7,960	8,266	7,720	8,045	7,606
Other Revenue	441.93	441.93	163.98	562.24	208.77	110.76
Revenue	8,083	8,401	8,430	8,282	8,254	7,717
Revenue Growth (YoY)	-4.31%	-0.34%	1.79%	0.35%	6.95%	-4.96%
Cost of Revenue	4,681	4,771	4,544	4,855	4,865	4,409
Gross Profit	3,402	3,631	3,886	3,427	3,389	3,308
Selling, General & Admin	2,446	2,597	2,983	2,812	2,779	2,665
Research & Development	109.29	106.76	94.2	69.65	100.52	128.45
Other Operating Expenses	62.47	81.5	84.64	-57.25	64.56	-7.63
Operating Expenses	2,628	2,831	3,206	2,864	2,980	2,793
Operating Income	774	800.18	679.83	563.54	409.19	515.53
Interest Expense	-33.88	-26.36	-21.61	-40.73	-33.59	-29.16
Interest & Investment Income	28.53	27.78	38.14	12.05	156.1	23.43
Currency Exchange Gain (Loss)	1.92	1.92	2.08	3.08	-3.48	-6.38
Other Non Operating Income (Expenses)	14.33	13.16	7.55	-27.97	-7.25	-12.36
EBT Excluding Unusual Items	784.9	816.67	705.99	509.97	520.97	491.06
Gain (Loss) on Sale of Investments	7.21	6.92	1.03	10.67	-0.96	-1.36
Gain (Loss) on Sale of Assets	0.74	1.01	1.04	15.21	2.2	51.29
Asset Writedown	2.2	-2.04	-30.12	-57.73	-0.29	-0.36
Other Unusual Items	112.01	112.01	108.45	-0.84	109.37	-0.14
Pretax Income	907.07	934.57	786.38	477.29	631.29	540.49
Income Tax Expense	187.96	183.35	143.7	91.83	118.07	78.3
Earnings From Continuing Operations	719.1	751.22	642.67	385.46	513.21	462.18
Minority Interest in Earnings	-111.79	-103.14	-101.96	-2.28	-5.55	-5.33
Net Income	607.32	648.08	540.71	383.18	507.67	456.86
Net Income to Common	607.32	648.08	540.71	383.18	507.67	456.86
Net Income Growth	12.27%	19.86%	41.11%	-24.52%	11.12%	0.56%
Shares Outstanding (Basic)	749	754	762	751	758	759
Shares Outstanding (Diluted)	749	754	762	751	758	759
Shares Change (YoY)	-1.68%	-1.05%	1.36%	-0.84%	-0.19%	-0.33%
EPS (Basic)	0.81	0.86	0.71	0.51	0.67	0.60
EPS (Diluted)	0.81	0.86	0.71	0.51	0.67	0.60
EPS Growth	14.19%	21.13%	39.22%	-23.88%	11.33%	0.89%
Free Cash Flow	691.52	728.63	644.69	152.15	15.46	251.21
Free Cash Flow Per Share	0.92	0.97	0.85	0.20	0.02	0.33
Dividend Per Share	0.300	0.300	0.200	0.160	0.270	0.230
Dividend Growth	50.00%	50.00%	25.00%	-40.74%	17.39%	15.00%
Gross Margin	42.09%	43.22%	46.10%	41.38%	41.06%	42.87%
Operating Margin	9.58%	9.52%	8.06%	6.80%	4.96%	6.68%
Profit Margin	7.51%	7.71%	6.41%	4.63%	6.15%	5.92%
Free Cash Flow Margin	8.55%	8.67%	7.65%	1.84%	0.19%	3.26%
EBITDA	935.97	964.84	855.23	744.03	568.04	666.42
EBITDA Margin	11.58%	11.48%	10.14%	8.98%	6.88%	8.64%
D&A For EBITDA	161.97	164.66	175.4	180.49	158.86	150.89
EBIT	774	800.18	679.83	563.54	409.19	515.53
EBIT Margin	9.58%	9.52%	8.06%	6.80%	4.96%	6.68%
Effective Tax Rate	20.72%	19.62%	18.27%	19.24%	18.70%	14.49%
Revenue as Reported	8,083	8,401	8,430	8,282	8,254	7,717

Source: S&P Global Market Intelligence. Standard template. Financial Sources.